adidas (ADS) Given a €220.00 Price Target by Baader Bank Analysts

Share on StockTwits

Baader Bank set a €220.00 ($255.81) price target on adidas (FRA:ADS) in a research report sent to investors on Wednesday. The brokerage currently has a buy rating on the stock.

Several other research firms have also recently weighed in on ADS. Berenberg Bank set a €207.00 ($240.70) price objective on adidas and gave the stock a neutral rating in a research report on Wednesday, July 25th. HSBC set a €255.00 ($296.51) price objective on adidas and gave the stock a buy rating in a research report on Monday, October 15th. Credit Suisse Group set a €243.00 ($282.56) price objective on adidas and gave the stock a buy rating in a research report on Tuesday, July 24th. Deutsche Bank set a €210.00 ($244.19) price objective on adidas and gave the stock a neutral rating in a research report on Monday, August 13th. Finally, Macquarie set a €260.00 ($302.33) price objective on adidas and gave the stock a buy rating in a research report on Monday, October 15th. Ten analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The company has an average rating of Buy and a consensus price target of €224.60 ($261.16).

Shares of FRA:ADS opened at €203.90 ($237.09) on Wednesday. adidas has a 12-month low of €163.65 ($190.29) and a 12-month high of €201.01 ($233.73).

About adidas

adidas AG, together with its subsidiaries, designs, develops, produces, and markets athletic and sports lifestyle products worldwide. It offers footwear; apparel; and hardware, such as bags and balls under the adidas, Reebok, and adidas Golf brands. The company is also involved in Y-3 label business activities; and the operation of Runtastic, a digital health and fitness space.

Further Reading: Why is the ex-dividend date different from the record date?

Analyst Recommendations for adidas (FRA:ADS)

Receive News & Ratings for adidas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for adidas and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.